Elizabeth R. Plimack is an Associate Professor of Medical Oncology and Director of Genitourinary Clinical Research at Fox Chase Cancer Center (FCCC). She is an expert on the treatment of genitourinary malignancies with a focus on bladder cancer. Her research effort is directed towards the discovery of novel therapeutic approaches and predictive biomarkers for patients with advanced bladder cancer. Dr. Plimack has extensive clinical trial experience with immunotherapies and novel combination therapies. She serves on the National Comprehensive Cancer Network guidelines panel for Bladder Cancer, the ASCO GU Program Committee, the Bladder Cancer Advocacy Network Think Tank Steering Committee, and on the American Joint Committee on Cancer (AJCC) Kidney/Urinary Tract Expert Panel. Dr. Plimack received her undergraduate degree from Yale University and completed her M.D. degree and residency in Internal Medicine at the New York University School of Medicine. She went on to a Medical Oncology Fellowship at the MD Anderson Cancer Center, and received a Master’s in Patient Based Biologic Research from the University of Texas Graduate School of Biomedical Science.